Search

Author/Creator Fogarty, P.

1. CLINICO‐BIOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR AGRESSIVE MANTLE CELL LYMPHOMA PATIENTS INCLUDED IN CLINICAL TRIALS. A LYSA STUDY. (12th June 2019)

Authors:
Baldacini, M.; Burroni, B.; Le Gouill, S.; Gressin, R.; Hermine, O.; Traverse‐glehen, A.; Martin, A.; Moreau, A.; Bene, M.; Fogarty, P.; Canioni, D.; Fornecker, L.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P1186: A LARGE FRENCH REAL WORLD MULTICENTRIC PROSPECTIVE COHORT OF PATIENTS WITH LYMPHOMA (REALYSA STUDY): DESCRIPTION OF THE DIFFUSE LARGE B CELL LYMPHOMA PATIENTS IN REAL WORLD IN FRANCE. (23rd June 2022)

Authors:
Ghesquieres, H.; Cherblanc, F.; Belot, A.; Camus, V.; Thokagevistk, K.; Bouabdallah, K.-K.; Esnault, C.; Fornecker, L.-M.; Micon, S.; Bijou, F.; Haioun, C.; Morineau, N.; Ysebaert, L.; Damaj, G.; Le Gouill, S.; Guidez, S.; Morschhauser, F.; Thiéblemont, C.; Chauchet, A.; Gressin, R.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1072
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels. (10th October 2014)

Authors:
Shapiro, A. D.; Ragni, M. V.; Kulkarni, R.; Oldenberg, J.; Srivastava, A.; Quon, D. V.; Pasi, K. J.; Hanabusa, H.; Pabinger, I.; Mahlangu, J.; Fogarty, P.; Lillicrap, D.; Kulke, S.; Potts, J.; Neelakantan, S.; Nestorov, I.; Li, S.; Dumont, J. A.; Jiang, H.; Brennan, A.
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 12:Number 11(2014:Nov.)
Page Start:
1788
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗